Anne Sempowski Ward
CIK: 0001790117
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026VNDA
Vanda Pharmaceuticals Inc.
Award(A)Direct41.6K shares- - May 28, 2026SPSC
SPS COMMERCE INC
Award(A)Direct3.7K shares- - Jun 5, 2025VNDA
Vanda Pharmaceuticals Inc.
Award(A)Direct59.2K shares- - May 13, 2025SPSC
SPS COMMERCE INC
Award(A)Direct1.3K shares-
1-4 of 4 transactions
About Ward Anne Sempowski
Ward Anne Sempowski (SEC CIK 0001790117) files insider reports with the SEC as Director of Vanda Pharmaceuticals Inc. (VNDA) and Director of SPS COMMERCE INC (SPSC).
Signal8 holds 4 ownership filings by Ward Anne Sempowski, all Form 4s, filed between May 15, 2025 and Jun 8, 2026. Those filings report 4 transactions, from May 13, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ward Anne Sempowski's filings is in MINNEAPOLIS, MN.
Recent filings by Ward Anne Sempowski
Other insiders filing for Vanda Pharmaceuticals Inc. (VNDA)
- McGuire Daniel Patrick, SVP, GC and Secretary
- Chrousos Phaedra, Director
- Duncan Charles Cliff, Director
- DUGAN RICHARD W, Director
- Honore Tage, Director
- Mitchell Stephen Ray, Director